Cardiovascular Diseases

The site is advancing research on cardiovascular disease, targeting conditions that affect the heart and blood vessels.

  • Acute myocardial infarction
  • Atrial fibrillation
  • Heart failure
  • Atherosclerotic cardiovascular disease
  • Stroke prevention

Ongoing studies aim to evaluate new therapeutic options, improve long‑term safety, and reduce major cardiovascular events for patients at risk.

Immune System Diseases

Research at this centre includes innovative work on autoimmune disorders that impair neuromuscular and central nervous system function.

  • Generalized Myasthenia Gravis
  • Ocular Myasthenia Gravis
  • Relapsing Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Progressive Forms of Multiple Sclerosis

These trials focus on testing novel biologics and immune‑modulating agents to improve disease control and quality of life.

Musculoskeletal Diseases

The facility conducts studies on musculoskeletal conditions that cause pain, weakness, and functional limitation.

  • Chronic non‑specific low back pain
  • Upper‑limb spasticity after stroke
  • Distal sensory polyneuropathy
  • Botulinum toxin injection for spasticity
  • Muscle‑related pain syndromes

The goal is to assess pain relief, functional improvement, and safety of new analgesic and injectable therapies.

Nervous System Diseases

A major focus is on neurodegenerative and cognitive disorders, seeking treatments that modify disease progression.

  • Alzheimer disease
  • Early Alzheimer’s disease with inflammatory biomarkers
  • Mild cognitive impairment
  • Dementia of the Alzheimer’s type
  • Tauopathies
  • Neurodegenerative diseases
  • Multiple Sclerosis (relapsing and progressive)

Studies evaluate disease‑modifying agents, cognitive outcomes, and biomarker changes to slow decline and improve daily functioning.

Nutritional and Metabolic Diseases

The centre also investigates metabolic and nutritional disorders that impact weight and systemic health.

  • Obesity
  • Overweight
  • Metabolic syndrome
  • Diabetic peripheral neuropathic pain
  • Weight‑management therapies

Clinical work aims to test new weight‑loss agents and assess their impact on metabolic parameters and safety profiles.